Pathways Picks May 24: EPA-FDA Chatter, Review Redesign, EU Dashboard, and More
In this week’s roundup: House Energy and Commerce Republicans are seeking a joint briefing from EPA and FDA on the impact of recently proposed ethylene oxide restrictions on medical device supply; CDRH is eyeing a premarket “redesign” in the name of simplicity, and has opened up online progress tracking of Pre-Submissions; the EU is preparing to launch a periodically updated dashboard on notified body performance; and updates from CMS, the Federal Trade Commission, UK NICE, and more.